Literature DB >> 21726810

Caspase-2-mediated cleavage of Mdm2 creates a p53-induced positive feedback loop.

Trudy G Oliver1, Etienne Meylan, Gregory P Chang, Wen Xue, James R Burke, Timothy J Humpton, Diana Hubbard, Arjun Bhutkar, Tyler Jacks.   

Abstract

Caspase-2 is an evolutionarily conserved caspase, yet its biological function and cleavage targets are poorly understood. Caspase-2 is activated by the p53 target gene product PIDD (also known as LRDD) in a complex called the Caspase-2-PIDDosome. We show that PIDD expression promotes growth arrest and chemotherapy resistance by a mechanism that depends on Caspase-2 and wild-type p53. PIDD-induced Caspase-2 directly cleaves the E3 ubiquitin ligase Mdm2 at Asp 367, leading to loss of the C-terminal RING domain responsible for p53 ubiquitination. As a consequence, N-terminally truncated Mdm2 binds p53 and promotes its stability. Upon DNA damage, p53 induction of the Caspase-2-PIDDosome creates a positive feedback loop that inhibits Mdm2 and reinforces p53 stability and activity, contributing to cell survival and drug resistance. These data establish Mdm2 as a cleavage target of Caspase-2 and provide insight into a mechanism of Mdm2 inhibition that impacts p53 dynamics upon genotoxic stress.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726810      PMCID: PMC3160283          DOI: 10.1016/j.molcel.2011.06.012

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  58 in total

1.  Activation of an MDM2-specific caspase by p53 in the absence of apoptosis.

Authors:  R Pochampally; B Fodera; L Chen; W Lu; J Chen
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  In situ trapping of activated initiator caspases reveals a role for caspase-2 in heat shock-induced apoptosis.

Authors:  Shine Tu; Gavin P McStay; Louis-Martin Boucher; Tak Mak; Helen M Beere; Douglas R Green
Journal:  Nat Cell Biol       Date:  2005-12-18       Impact factor: 28.824

4.  Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage.

Authors:  Eric Batchelor; Caroline S Mock; Irun Bhan; Alexander Loewer; Galit Lahav
Journal:  Mol Cell       Date:  2008-05-09       Impact factor: 17.970

5.  Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.

Authors:  R Honda; H Yasuda
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

6.  Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria.

Authors:  Yin Guo; Srinivasa M Srinivasula; Anne Druilhe; Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  J Biol Chem       Date:  2002-02-06       Impact factor: 5.157

7.  The biochemical mechanism of caspase-2 activation.

Authors:  B C Baliga; S H Read; S Kumar
Journal:  Cell Death Differ       Date:  2004-11       Impact factor: 15.828

8.  Caspase-2 cleavage of BID is a critical apoptotic signal downstream of endoplasmic reticulum stress.

Authors:  John-Paul Upton; Kathryn Austgen; Mari Nishino; Kristen M Coakley; Andrew Hagen; Dan Han; Feroz R Papa; Scott A Oakes
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

Review 9.  Caspase 2 in apoptosis, the DNA damage response and tumour suppression: enigma no more?

Authors:  Sharad Kumar
Journal:  Nat Rev Cancer       Date:  2009-11-05       Impact factor: 60.716

10.  Caspase 2-mediated tumor suppression involves survivin gene silencing.

Authors:  M Guha; F Xia; C M Raskett; D C Altieri
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more
  68 in total

Review 1.  Caspase-2: the orphan caspase.

Authors:  L Bouchier-Hayes; D R Green
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  p53 and MDM2 are involved in the regulation of osteocalcin gene expression.

Authors:  Hankui Chen; Kevin Kolman; Natalie Lanciloti; Michael Nerney; Emily Hays; Chet Robson; Nalini Chandar
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

3.  Development and characterization of 5 canine B-cell lymphoma cell lines.

Authors:  Allison L Zwingenberger; William Vernau; Changying Shi; Wensheng Yan; Xinbin Chen; Ira K Gordon; Michael S Kent
Journal:  Leuk Res       Date:  2011-12-01       Impact factor: 3.156

Review 4.  Alterations in the nucleocytoplasmic transport in apoptosis: Caspases lead the way.

Authors:  Gelina S Kopeina; Evgeniia A Prokhorova; Inna N Lavrik; Boris Zhivotovsky
Journal:  Cell Prolif       Date:  2018-06-26       Impact factor: 6.831

Review 5.  P53-induced protein with a death domain (PIDD): master of puppets?

Authors:  F J Bock; L Peintner; M Tanzer; C Manzl; A Villunger
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 6.  Once and only once: mechanisms of centriole duplication and their deregulation in disease.

Authors:  Erich A Nigg; Andrew J Holland
Journal:  Nat Rev Mol Cell Biol       Date:  2018-01-24       Impact factor: 94.444

7.  Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice.

Authors:  S Shalini; L Dorstyn; C Wilson; J Puccini; L Ho; S Kumar
Journal:  Cell Death Differ       Date:  2012-02-17       Impact factor: 15.828

8.  Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.

Authors:  Neelu Puri; Ryan T Pitman; Richard E Mulnix; Terrianne Erickson; Audra N Iness; Connie Vitali; Yutong Zhao; Ravi Salgia
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679

9.  Arrestins in apoptosis.

Authors:  Seunghyi Kook; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

Review 10.  Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Authors:  Tiffany Devine; Mu-Shui Dai
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.